Gisela Schott

Down’s syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials

Michael Dördelmann, Martin Schrappe, Andreas Reiter et al. · Leukemia · 1998 · 118 citations

Down Syndrome, Hematological Malignancy, Treatment Outcome +6

Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia

Richard Ratei, Christian Sperling, Leonid Karawajew et al. · Annals of Hematology · 1998 · 70 citations

Hematological Malignancy, Pediatric Hematology, Medicine +9

Immunophenotypic and clinical features of T‐cell receptor γδ⁺ T‐lineage acute lymphoblastic leukaemia

Gisela Schott, Christian Sperling, Martin Schrappe et al. · British Journal of Haematology · 1998 · 33 citations

Membrane Cd3+ T-all, Tcr-alphabeta Positivity, Lymphocyte Development +17

Does the Pharmaceutical Industry Influence Guidelines? Two Examples From Germany

Gisela Schott, Claudia Dünnweber, Bernd Mühlbauer et al. · Deutsches Ärzteblatt international · 2013 · 32 citations

Management of financial conflicts of interests in clinical practice guidelines in Germany: results from the public database GuidelineWatch

Hendrik Napierala, Luise SchäFer, Gisela Schott et al. · BMC Medical Ethics · 2018 · 22 citations · Full text